![](https://monteverdelaw.com/wp-content/uploads/case-logo/flexion-therapeutics-inc.png)
Flexion Therapeutics, Inc. (FLXN) relating to its proposed acquisition by Pacira BioSciences, Inc. Under the terms of the agreement, FLXN shareholders will receive $8.50 in cash per share they own.
Flexion Therapeutics, Inc. (FLXN) relating to its proposed acquisition by Pacira BioSciences, Inc. Under the terms of the agreement, FLXN shareholders will receive $8.50 in cash per share they own.